Skip to main content
. 2017 May 11;37(3):BSR20160447. doi: 10.1042/BSR20160447

Figure 4. PRDX2 depletion reduces the resistance of colon cancer cells to 5-FU in vivo.

Figure 4

Five female BALB/c-nu mice were placed in each group. The shCont group treated with 5-FU and shPRDX2 group with PBS injection had longer survival times than nude mice in the shCont group with PBS injection. However, nude mice in the shPRDX2 group with 5-FU treatment had the longest survival time compared with the other three groups; *P<0.05.